Trial of Atezolizumab, Bevacizumab, and Tiragolumab in Patients With Microsatellite Stable, Metastatic Colorectal Cancer

NCT06784947 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Microsatellite Stable (MSS) Colorectal Cancer (CRC)
Metastatic Colorectal Cancer (CRC)
Colorectal Cancer Stage IV

Interventions

PROCEDURE: Pre-Treatment Biopsy
PROCEDURE: On-Treatment Biopsy
DRUG: Tiragolumab
DRUG: Atezolizumab
DRUG: Bevacizumab

Sponsor

University of Colorado, Denver

Collaborators

[object Object]